|
Friday 31st October 2003 |
Text too small? |
The shares investors bought at $2.50 in September 2001 are trading at $1.86 but well above their low of $1.10 last year.
The company has benefited from an increase in patients opting for private medical and surgical attention as public hospitals grapple with unconscionable waiting lists.
It has made no secret of it also looking to benefit from an ageing population, pitting the business squarely in the healthcare sector.
Profit for the year ended March 31 increased 16% to $793,000 after absorbing $258,000 in unusual costs associated with a Securities Commission inquiry into the company's prospectus and listing.
Since then it has appointed former PricewaterhouseCoopers senior manager John Dixon as chief executive and has acquired local counterpart Bowen Hospital.
The improvement coincides with Sir Selwyn Cushing's family trust acquiring a 5% stake.
Wakefield will be looking to consolidate its gains while extracting all it can from the Bowen acquisition. The company is forecasting a "significant increase" in net profit for the 2004 year and should achieve that if patient numbers continue at present levels.
No comments yet
SCT - Scott Secures NZ$20m of Global MHL Contracts
SPK - Spark appoints Vince Hawksworth as Chair
August 18th Morning Report
AIA - July 2026 Monthly Traffic Update
MEL - Appointment of Non-Executive Director to Meridian Board
SML - Synlait ELT update
August 17th Morning Report
CMO - Preliminary result and dividend
GXH - Green Cross Health Limited (GXH) CEO Resignation
MEL - Meridian Energy monthly operating report for July 2026